183 related articles for article (PubMed ID: 16103966)
1. [Hepatitis B and C risk factors in Germany--results of the national surveillance].
Walter J; Radun D; Claus H; Hamouda O; Stark K
Gesundheitswesen; 2005 Jul; 67(7):441-7. PubMed ID: 16103966
[TBL] [Abstract][Full Text] [Related]
2. Surveillance for acute viral hepatitis--United States, 2006.
Wasley A; Grytdal S; Gallagher K;
MMWR Surveill Summ; 2008 Mar; 57(2):1-24. PubMed ID: 18354374
[TBL] [Abstract][Full Text] [Related]
3. Acute hepatitis B 14 years after the implementation of universal vaccination in Italy: areas of improvement and emerging challenges.
Mele A; Tosti ME; Mariano A; Pizzuti R; Ferro A; Borrini B; Zotti C; Lopalco P; Curtale F; Balocchini E; Spada E;
Clin Infect Dis; 2008 Mar; 46(6):868-75. PubMed ID: 18269332
[TBL] [Abstract][Full Text] [Related]
4. Surveillance for acute viral hepatitis--United States, 2005.
Wasley A; Miller JT; Finelli L;
MMWR Surveill Summ; 2007 Mar; 56(3):1-24. PubMed ID: 17363893
[TBL] [Abstract][Full Text] [Related]
5. Incidence and routes of transmission of hepatitis B virus in England and Wales, 1995-2000: implications for immunisation policy.
Hahné S; Ramsay M; Balogun K; Edmunds WJ; Mortimer P
J Clin Virol; 2004 Apr; 29(4):211-20. PubMed ID: 15018847
[TBL] [Abstract][Full Text] [Related]
6. Incidence and risk factors for acute hepatitis B in the United States, 1982-1998: implications for vaccination programs.
Goldstein ST; Alter MJ; Williams IT; Moyer LA; Judson FN; Mottram K; Fleenor M; Ryder PL; Margolis HS
J Infect Dis; 2002 Mar; 185(6):713-9. PubMed ID: 11920288
[TBL] [Abstract][Full Text] [Related]
7. Experience with the new German hepatitis B vaccination strategy since 1995.
Krämer A; Prüfer-Krämer L
Int J STD AIDS; 2002 Dec; 13 Suppl 2():35-7. PubMed ID: 12537724
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of hepatitis B and C infection in a methadone clinic population: implications for hepatitis B vaccination.
Carter H; Robinson G; Hanlon C; Hailwood C; Massarotto A
N Z Med J; 2001 Jul; 114(1136):324-6. PubMed ID: 11548096
[TBL] [Abstract][Full Text] [Related]
9. [Hepatitis B vaccination of children and adolescents].
Jilg W
Fortschr Med; 1997 Apr; 115(10):26, 29-32, 33. PubMed ID: 9206683
[TBL] [Abstract][Full Text] [Related]
10. Changing serological status and low vaccination-induced protection rates against hepatitis B characterize chronic hepatitis C virus-infected injecting drug users in Greece: need for immunization policy.
Elefsiniotis IS; Pantazis KD; Ketikoglou ID; Koutsounas SI; Tsianos EV
Eur J Gastroenterol Hepatol; 2006 Nov; 18(11):1227-31. PubMed ID: 17033445
[TBL] [Abstract][Full Text] [Related]
11. Hepatitis B in Italy: where we are ten years after the introduction of mass vaccination.
Mele A; Stroffolini T; Zanetti AR
J Med Virol; 2002 Jul; 67(3):440-3. PubMed ID: 12116041
[TBL] [Abstract][Full Text] [Related]
12. Acute hepatitis delta virus infection in Italy: incidence and risk factors after the introduction of the universal anti-hepatitis B vaccination campaign.
Mele A; Mariano A; Tosti ME; Stroffolini T; Pizzuti R; Gallo G; Ragni P; Zotti C; Lopalco P; Curtale F; Balocchini E; Spada E;
Clin Infect Dis; 2007 Feb; 44(3):e17-24. PubMed ID: 17205431
[TBL] [Abstract][Full Text] [Related]
13. Acute hepatitis A in Italy: incidence, risk factors and preventive measures.
Tosti ME; Spada E; Romanò L; Zanetti A; Mele A;
J Viral Hepat; 2008 Oct; 15 Suppl 2():26-32. PubMed ID: 18837830
[TBL] [Abstract][Full Text] [Related]
14. Use of enhanced surveillance for hepatitis C virus infection to detect a cluster among young injection-drug users--new York, November 2004-April 2007.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2008 May; 57(19):517-21. PubMed ID: 18480744
[TBL] [Abstract][Full Text] [Related]
15. Modelling the force of infection for hepatitis B and hepatitis C in injecting drug users in England and Wales.
Sutton AJ; Gay NJ; Edmunds WJ; Hope VD; Gill ON; Hickman M
BMC Infect Dis; 2006 Jun; 6():93. PubMed ID: 16762050
[TBL] [Abstract][Full Text] [Related]
16. [Increased risk of hepatitis B due to incomplete or untimely immunisation in one-quarter of infants of hepatitis-B-virus carriers].
van der Ploeg CP; Kateman H; Vermeer-de Bondt PE; Verkerk PH
Ned Tijdschr Geneeskd; 2004 Sep; 148(37):1820-4. PubMed ID: 15495511
[TBL] [Abstract][Full Text] [Related]
17. Hepatitis B vaccination coverage among adults--United States, 2004.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2006 May; 55(18):509-11. PubMed ID: 16691181
[TBL] [Abstract][Full Text] [Related]
18. [Hepatitis vaccination of adults].
Jost R
Schweiz Med Wochenschr; 1998 Jul; 128(27-28):1104-9. PubMed ID: 9691345
[TBL] [Abstract][Full Text] [Related]
19. [Hepatitis B and C in 1997].
Kuszewski K
Przegl Epidemiol; 1999; 53(1-2):75-81. PubMed ID: 10402853
[TBL] [Abstract][Full Text] [Related]
20. A comparison between the force of infection estimates for blood-borne viruses in injecting drug user populations across the European Union: a modelling study.
Sutton AJ; Hope VD; Mathei C; Mravcik V; Sebakova H; Vallejo F; Suligoi B; Brugal MT; Ncube F; Wiessing L; Kretzschmar M
J Viral Hepat; 2008 Nov; 15(11):809-16. PubMed ID: 18761605
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
